1Zhao X, Wei YQ, Peng ZL. Induction of T cell responses against qutologous ovarian tumor with whole tumor cell lysate-pulsed dendriticc cells. Immunol Invest, 2001 ; 30(1) : 33 - 45.
2Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature, 1998;392(3) :245-252.
3Maraskovsdy E, Brasel K, Teepe M, et al. Dramatic increase in the number of functionally mature dendritic cells in Flt3 liganti-treated mice: multiple dendritic cell subpopulations identified. J Exp Med, 1996; 184(2):1953-1962.
4Cavanagh LL, Saal RJ, Grimmett KL, et al. Proliferation inederived dendritic cell cultures is caused by progenitor cells capable of myeloid differentiation. Blood, 1998; 92 ( 1 ) :1598- 1607.
5Maraskovsky E, Dary E, Roux E, et al. In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood, 2000; 96(1) :878-884.
6Chu CS, Woo EY, Toll AJ, et al. Tumor-associated macrophages as a source of functional dendritic cells in ovarian cancer patients. Clin Immunol, 2002; 102(3) :291-301.
7Anichini A, Mortarini R, MaccaUi C, et al. Cytotxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HL A-restricted immune repertoire to melanoma. J Immunol, 1996;156(3) :208-217.
8Celluzzi CM, Mayordomv JI, Storkus WJ, et al. Peptidepulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J Exp Med, 1996; 183(2) :283-287.
9Song W, Kong HL, Carpenter H,et al. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antiturnor immunity. J Exp Med, 1997; 186(2) : 1247- 1256.
10Bockzkowski D, Nair S,Snyder D, et al. Dendritic cells pulsed with PNA are potent antigen presenting cells in vitro and in vivo. J Exp Med, 1996;184(3):465-472.
